For the Inventor, By the Inventor

Enter assignee name

Exton, PA, United States of America

Viropharma Incorporated

USPTO Granted Patents = 23

% Expired Patents = 21.7

CIPO Patents = 1

Trademarks = 1

Forward Citations = 313

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Theodore John Nitz (14 out of 45 patents)

Thomas R Bailey (12 out of 56 patents)

Guy D Diana (8 out of 73 patents)

4. Dorothy C Young (7 out of 7 patents)

5. William P Gorczyca (5 out of 5 patents)

6. Christopher J Burns (3 out of 52 patents)

7. Daniel C Pevear (3 out of 38 patents)

8. John Swestock (3 out of 3 patents)

9. Yijun Deng (2 out of 27 patents)

10. Susan R Rippin (2 out of 30 patents)

11. Hao Feng (2 out of 33 patents)

12. David J Rys (2 out of 8 patents)

13. Thomas A Lessen (2 out of 8 patents)

14. Thomas Faitg (2 out of 4 patents)

15. Alfred Michael Del Vecchio (2 out of 3 patents)

23 patents: Sort by Forward Citations

1. 8940707 - Maribavir isomers, compositions, methods of making and methods of using (2015-01-27),

2. 8546344 - Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole (2013-10-01),

3. 8541391 - Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole (2013-09-24),

4. 8371092 - Apparatus and methods for reducing capsule elongation (2013-02-12),

5. 7666863 - Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases (2010-02-23),

6. 7585884 - Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents (2009-09-08),

7. 7429606 - Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents (2008-09-30),

8. 7408078 - Anthranilic acid derivatives useful in treating infection with hepatitis C virus (2008-08-05),

9. 7265152 - Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases (2007-09-04),

10. 7217730 - Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus (2007-05-15),

11. 6541472 - Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseases (2003-04-01),

12. 6495580 - Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases (2002-12-17),

13. 6440985 - Methods for treating viral infections (2002-08-27),

14. 6316492 - Methods for treating or preventing viral infections and associated diseases (2001-11-13),

15. 6271373 - Compounds, compositions and methods for treating influenza (2001-08-07),

Company Overview

Viropharma Incorporated is a biopharmaceutical company based in Exton, Pennsylvania, specializing in the development and commercialization of innovative therapies for serious diseases. The company focuses on addressing unmet medical needs, particularly in the areas of infectious diseases and rare conditions. Viropharma's research emphasizes the advancement of treatments that improve patient outcomes and enhance quality of life, leveraging cutting-edge science and technology to bring new solutions to the healthcare market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

23 Patents

#11 in Exton, PA

#526 in Pennsylvania

#14,428 in US

#27,685 in the World

Exton, PA, United States of America

Viropharma Incorporated

Forward Citations = 313

44 inventors:

Theodore John Nitz (14 out of 45 patents)

Thomas R Bailey (12 out of 56 patents)

Guy D Diana (8 out of 73 patents)

4. Dorothy C Young (7 out of 7 patents)

5. William P Gorczyca (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viropharma Incorporated. Retrieved from https://idiyas.com/company/viropharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…